A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat
Authors:
- Omar M.E. Abdel-SalamOAOmar M.E. Abdel-Salam
- Ayman R. BaiuomyABAyman R. Baiuomy
- Amany AmeenAAAmany Ameen
- Nabila S. HassanNHNabila S. Hassan
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 51 (1) , 59-67
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Liver extracellular matrix in health and diseaseThe Journal of Pathology, 2003
- Effects of heparin on liver fibrosis in patients with chronic hepatitis BWorld Journal of Gastroenterology, 2003
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and SafetyChest, 2001
- Comparative Pharmacokinetics of LMWHsSeminars in Thrombosis and Hemostasis, 2000
- Low-molecular-weight heparins in the treatment of venous thromboembolismTrials, 2000
- New aspects of hepatic fibrosisJournal of Hepatology, 2000
- Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight HeparinsDrugs, 1990
- Oligosaccharide mapping of low-molecular-weight heparins: structure and activity differencesJournal of Medicinal Chemistry, 1990
- Toxicity Tests1964